Showing results (2241-2250 of 3,105) with videos related to
Sort By:
Pageof 311
Drug Safety|September 2, 2021
Eritrean Pharmacovigilance System: Key Strategies, Success Stories, Challenges and Lessons LearnedMulugeta Russom, Iyassu Bahta, Merhawi DebesaiDrug Safety|February 22, 2023
Preventable Deaths Involving Medicines: A Systematic Case Series of Coroners' Reports 2013-22Harrison S France, Jeffrey K Aronson, Carl Heneghan, et al.Drug Safety|November 17, 2022
Development and Evaluation of the Algorithm CErtaInty Tool (ACE-IT) to Assess Electronic Medical Record and Claims-based Algorithms' Fit for Purpose for Safety OutcomesSonal Singh, Julie Beyrer, Xiaofeng Zhou, et al.Drug Safety|March 28, 2023
Core Data Elements for Pregnancy Pharmacovigilance Studies Using Primary Source Data Collection Methods: Recommendations from the IMI ConcePTION ProjectJonathan L Richardson, Alan Moore, Rebecca L Bromley, et al.Drug Safety|March 12, 2025
The Frequency of Drug-Induced Liver Injury Due to Antibiotics Among Hospitalised PatientsRobert A Björnsson, Sigurdur Sölvi Sigurdsson, Dagur Tjörvi Arnarson, et al.Drug Safety|February 14, 2025
Aggregation of Adverse Event Terms for Signal Detection and Labeling in Clinical TrialsRichard C Zink, Rebecca Lyzinski, Geoffrey MannDrug Safety|January 27, 2025
Sequential Epidemiological Analyses of Real-World Data: A Tool for Prospective Drug Safety Surveillance from the Rofecoxib ExampleSaad Hanif Abbasi, Lars Christian Lund, Jesper Hallas, et al.Drug Safety|November 2, 2024
Views on the Development and Use of a New Digital Adverse Drug Event Reporting Platform in Australia: A Qualitative StudyEyob Alemayehu Gebreyohannes, Christopher Thornton, Myra Thiessen, et al.Drug Safety|December 4, 2024
Prenatal Exposure to Proton Pump Inhibitors and Risk of Serious Infections in Offspring During the First Year of Life: A Nationwide Cohort StudyMylène Tisseyre, Mathis Collier, Nathanaël Beeker, et al.Drug Safety|December 5, 2024
Early Detection of Hearing Impairment Signals Post-mRNA COVID-19 Vaccination: A Disproportionality Analysis Study on French Pharmacovigilance DatabaseDalil Boulefaa, Haleh Bagheri, Francesco Salvo, et al.Pageof 311